tiprankstipranks
Fuse Medical (FZMD)
:FZMD
US Market
Holding FZMD?
Track your performance easily

Fuse Medical (FZMD) Technical Analysis

7 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Fuse Medical ’s (FZMD) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Fuse Medical is a Sell.
Fuse Medical ’s (FZMD) 20-Day exponential moving average is 0.10, while Fuse Medical ’s (FZMD) share price is $0.1, making it a Buy.
Fuse Medical ’s (FZMD) 50-Day exponential moving average is 0.09, while Fuse Medical ’s (FZMD) share price is $0.1, making it a Buy.

Fuse Medical (FZMD) Pivot Points

Jan 15, 2025, 05:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.12
0.12
0.12
0.12
0.12
0.12
0.12
Fibonacci
0.12
0.12
0.12
0.12
0.12
0.12
0.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Fuse Medical (FZMD) Moving Averages

Jan 15, 2025, 05:45 AM
Period
Simple
Exponential
MA5
0.11Buy
0.11Buy
MA10
0.10Buy
0.11Buy
MA20
0.11Buy
0.10Buy
MA50
0.08Buy
0.09Buy
MA100
0.06Buy
0.08Buy
MA200
0.07Buy
0.08Buy
Fuse Medical ’s (FZMD) 10-Day exponential moving average is 0.11, while Fuse Medical ’s (FZMD) share price is $0.1, making it a Buy.
Fuse Medical ’s (FZMD) 100-Day exponential moving average is 0.08, while Fuse Medical ’s (FZMD) share price is $0.1, making it a Buy.
Fuse Medical ’s (FZMD) stock price is $0.1 and Fuse Medical ’s (FZMD) 50-day simple moving average is 0.08, creating a Buy signal.
Fuse Medical ’s (FZMD) stock price is $0.1 and Fuse Medical ’s (FZMD) 100-day simple moving average is 0.06, creating a Buy signal.
Fuse Medical ’s (FZMD) stock price is $0.1 and Fuse Medical ’s (FZMD) 200-day simple moving average is 0.07, creating a Buy signal.

Fuse Medical (FZMD) Technical Indicators

Jan 15, 2025, 05:45 AM
Name
Value
Implied Action
RSI (14)
62.21
Neutral
STOCH (9,6)
101.87
Sell
STOCHRSI (14)
101.69
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
54.20
Sell
Williams %R
1.69
Sell
CCI (14)
178.95
Sell
ATR (14)
0.03
-
Ultimate Oscillator
92.79
Buy
ROC
0.00
Sell
Fuse Medical ’s (FZMD) Relative Strength Index (RSI) is 62.21, creating a Neutral signal.
Fuse Medical ’s (FZMD) Trend Strength Indicator (ADX) is 54.20, creating a Sell signal.
Fuse Medical ’s (FZMD) Commodity Channel Index (CCI) is 178.95, creating a Sell signal.

FAQ

Is FZMD a Buy, Hold, or Sell?
Based on FZMD’s technical indicators, FZMD is a Buy.
    What is FZMD’s RSI (14)?
    FZMD’s RSI (14) is 62.21, which suggests FZMD is a Neutral.
      What is FZMD’s MACD?
      FZMD’s MACD is <0.01, which suggests FZMD is a Sell.
        What is FZMD’s 5-day moving average?
        FZMD’s 5-day moving average is 0.11, which suggests FZMD is a Buy.
          What is FZMD’s 20-day moving average?
          FZMD 20-day moving average is 0.11, which suggests FZMD is a Buy.
            What is FZMD’s 50-day moving average?
            FZMD’s 50-day moving average is 0.08, which suggests FZMD is a Buy.
              What is FZMD’s 200-day moving average?
              FZMD’s 200-day moving average is 0.07, which suggests FZMD is a Buy.
                What is FZMD’s Williams % R (14)?
                FZMD’s Williams % R (14) is 1.69, which suggests FZMD is a Sell.
                  What is FZMD’s CCI (14)?
                  FZMD’s CCI (14) is 178.95, which suggests FZMD is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis